Comparing Interparfums (NASDAQ:IPAR) & USANA Health Sciences (NYSE:USNA)

Interparfums (NASDAQ:IPAR) and USANA Health Sciences (NYSE:USNA) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Interparfums and USANA Health Sciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interparfums	0	3	4	1	2.75
USANA Health Sciences	1	1	0	0	1.50

Interparfums presently has a consensus target price of $116.17, suggesting a potential downside of 2.38%. Given Interparfums’ stronger consensus rating and higher possible upside, equities analysts plainly believe Interparfums is more favorable than USANA Health Sciences.

Profitability

This table compares Interparfums and USANA Health Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Interparfums	11.17%	15.21%	10.85%
USANA Health Sciences	-2.43%	3.41%	2.50%

Insider & Institutional Ownership

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 54.2% of USANA Health Sciences shares are owned by institutional investors. 43.7% of Interparfums shares are owned by insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Interparfums and USANA Health Sciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interparfums	$1.50 billion	2.54	$168.39 million	$5.23	22.75
USANA Health Sciences	$925.26 million	0.30	$10.76 million	($1.21)	-12.29

Interparfums has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Interparfums has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Summary

Interparfums beats USANA Health Sciences on 15 of the 15 factors compared between the two stocks.

About Interparfums

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.